Trastuzumab Package Insert

PATIENT INFORMATION A HALAVEN (HAL-ih-ven) HALAVEN (eribulin ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use HALAVEN safely and HALAVEN® (eribulin mesylate) injection, for intravenous use See 17 for PATIENT COUNSELING INFORMATION and FDA-approved Patient Labeling ... Retrieve Full Source

HIGHLIGHTS OF PRESCRIBING INFORMATION Uveitis (UV) (1.10 ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for ... Get Doc

HYCAMTIN IV Prescribing Information - HemOnc.org
Reversible single strand breaks. Topotecan binds to the topoisomerase I-DNA complex and prevents religation of these single strand breaks. The cytotoxicity of topotecan is thought to be ... Get Doc

Ancestim - Wikipedia
Ancestim is a recombinant methionyl human stem cell factor, branded by Amgen as StemGen. It was developed by Amgen and sold to Biovitrium, now Swedish Orphan Biovitrum, in December, 2008. ... Read Article

Kadcyla® (ado-trastuzumab Emtansine) - Moda Health
1. Kadcyla [package insert]. South San Francisco, CA; Genentech, Inc; July 2016. Accessed January 2018. 2. Referenced with permission from the NCCN Drugs & Biologics Compendium (NCCN Compendium®) ado-trastuzumab emtansine. National Comprehensive Cancer Network, 2018. ... View Document

Denileukin Diftitox - Wikipedia
Denileukin diftitox (trade name Ontak) was an antineoplastic agent, an engineered protein combining Interleukin-2 and Diphtheria toxin. Denileukin diftitox could bind to Interleukin-2 receptors and introduce the diphtheria toxin into cells that express those receptors, killing the cells. ... Read Article

Humanized Anti-HER-2 (Herceptin/Trastuzumab) ELISA Assay Kit
Conformance with its specifications, as set forth in the accompanying package insert. This warranty is expressly limited to the refund of the price of any defective Product or the replacement of any defective Product with new Product. This warranty applies only when ... Retrieve Document

HIGHLIGHTS OF PRESCRIBING INFORMATION Renal Toxicity May Be ...
Upon treatment initiation, the recommended Zometa doses for patients with reduced renal function (mild and moderate renal impairment) are listed in Table 1. ... Read Content

Nimotuzumab - Wikipedia
Nimotuzumab (h-R3, BIOMAb EGFR, Biocon, India; TheraCIM, CIMYM Biosciences, Canada; Theraloc, Oncoscience, Europe, CIMAher, Center of Molecular Immunology, Havana, Cuba) is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other countries for squamous cell carcinomas of the head and neck, and was ... Read Article

Reference ID: 3366104 - ZEVALIN
6. Transfer 1.3 mL of Zevalin (ibritumomab tiuxetan) to the reaction vial. Do not shake or agitate the vial contents. 7. Allow the labeling reaction to proceed at room temperature for 5 minutes. A shorter or longer reaction time may adversely alter the final labeled product. 8. ... Read Document

Benlysta IV & SC - GSKSource
2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE BENLYSTA (belimumab) is indicated for the treatment of adult patients with active, autoantibody-positive, systemic lupus erythematosus (SLE) who are receiving standard therapy. ... Return Document

Kadcyla (ado-trastuzumab Emtansine) - Caremark
Metastatic breast cancer who previously received trastuzumab and a taxane, separately or in combination. Patients should have either received prior therapy for metastatic disease, or developed disease recurrence during or within six months of completing adjuvant therapy. Compendial Use ... Read More

Trastuzumab In Female Breast Cancer Patients With Reduced ...
Domain of HER2, trastuzumab (Herceptin , Genentech, San Francisco, CA) has been shown to benefit patients with HER2+ breast cancer, alone or in combination with ... Doc Retrieval

Perjeta (pertuzumab) For Treatment Of Malignancies
Perjeta Package Insert: -FDA-approved indication and dosage: Indication Recommended Dose Metastatic Breast Cancer (MBC) MBC: For intravenous infusion only. Do not administer as an intravenous push or bolus. Administer Perjeta, trastuzumab and docetaxel by intravenous infusion every 3 weeks. ... Access This Document

MITOMYCIN FOR INJECTION, USP
Unreconstituted mitomycin stored at controlled room temperature is stable for the lot life indicated on the package. Avoid excessive heat (over 40°C). 2. Reconstituted Store dry powder at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature], protected from light. ... Get Document

INFeD® (IRON DEXTRAN INJECTION USP) Rx Only Revised: January 2014
Iron is absorbed over the ensuing 3 to 4 weeks. Various studies involving intravenously administered 59Fe iron dextran to iron deficient subjects, some of whom had coexisting diseases, have yielded half-life values ranging from 5 hours to more than 20 hours. ... Access This Document

PACKAGE LEAFLET - Medicines
Medicine called trastuzumab (for patients for whom anthracycline is not suitable and whose cancer cells have a protein on their surface called HER 2, see package leaflet of trastuzumab). after initial surgery following treatment with anthracycline and cyclophosphamide (AC) as an additional treatment. ... Fetch Full Source

Herceptin® (trastuzumab) - EmblemHealth
1. Herceptin [package insert]. South San Francisco, CA; Genentech, Inc; April 2017. Accessed October 2017. 2. Referenced with permission from the NCCN Drugs & Biologics Compendium (NCCN Compendium®) trastuzumab. National Comprehensive Cancer Network, 2017. The NCCN Compendium® is a derivative work of the NCCN Guidelines®. NATIONAL ... Access Document

NEW ZEALAND DATA SHEET Herceptin (trastuzumab)
Herceptin (trastuzumab) Herceptin 180501 1 1. PRODUCT NAME For full instructions on assay performance and interpretation please refer to the package inserts of validated FISH, CISH and SISH assays. Official recommendations on HER2 testing may also apply. ... View Document

Taxotere Prescribing Information - Home - Sanofi
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TAXOTERE safely and effectively. See full prescribing information for TAXOTERE. ... Get Document

HIGHLIGHTS OF PRESCRIBING INFORMATION Age Group Dosage ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CUBICIN safely and effectively. See full prescribing information ... Document Retrieval